Skip to main content

Jin Medical International Ltd.

corporate_fare Company Profile

Jin Medical International Ltd.

ZJYL·NASDAQ·Industrial Applications And Services·CIK 0001837821

Changzhou Zhongjin designs and manufactures wheelchairs and living aids products for people with disabilities, the elderly, and those recovering from injury. The company's business primarily focuses on wheelchairs. For the fiscal years ended September 30, 2025, 2024, and 2023, sales of wheelchairs and wheelchair components represented approximately 87.5%, 71.3%, and 96.5% of revenue, respectively. Sales of living aids products, such as oxygen concentrators and bathing machines, accounted for approximately 11.6%, 9.8%, and 3.1% of revenue for the same periods. In the fiscal year ended 2024, new products were introduced, including oxygen chambers, beauty instruments, and nano products, which represented 6.8%, 8.9%, and 3.2% of revenue, respectively. The majority of products are sold to dealers in Japan and China, with a smaller portion sold to dealers in other regions including the United States, Canada, Australia, Korea, Israel, and Singapore. Changzhou Zhongjin has been designing and manufacturing wheelchairs since 2006. Almost all wheelchairs currently for sale are manual wheelchairs, with over thirty models available across various price points. Electric wheelchairs, which the company began selling in 2018, accounted for approximately 1.7%, 0.5%, and 0.2% of revenue for the fiscal years ended September 30, 2025, 2024, and 2023, respectively. Mid to high-end wheelchairs and components are primarily for customers in Japan, while relatively lower-end wheelchairs and components target customers in China.

Jin Medical International Ltd. (NASDAQ:ZJYL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors ZJYL SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Jin Medical Shareholders Greenlight Sweeping Governance Overhaul and $105M Acquisition
  • Jin Medical International Amends Shareholder Meeting Date for Highly Dilutive Acquisition and Voting Power Shift
  • Jin Medical Proposes Transformational Acquisition, Massive Dilution, and CEO Control Consolidation
  • Jin Medical International Changes Auditor; Board Approves Without Audit Committee
  • Jin Medical Regains Nasdaq Compliance After Reverse Stock Split

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$20.69M
Net Income
$1.19M
Diluted EPS
$0.01
Op. Cash Flow
$2.9M
Free Cash Flow
-$3.73M
Gross Profit
$6.04M
Operating Income
$608.18K
Cash & Equivalents
$7.46M
Total Debt
$18.84M
Debt / Equity
0.64×
Net Margin
5.8%
Shares Outstanding
156.55M sh
Source: 20-F · filed 2026-02-10 · accession 0001213900-26-013870

Insider Transactions

ZJYL files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with Z →
$1.94 -0.06% today
52-week range · as of 2026-07-20 $1.64 – $17.18
Market cap
$15.03M
Volume
9.4K (0.5× avg)
3-mo avg 19.2K
Live data · 2026-07-29 09:34 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed ZJYL - Latest Insights

ZJYL
Jul 20, 2026, 4:55 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.90
Real-time Price: $1.94 info
Change: +$0.040 (+2%) info
Market Cap: $15.029M info
ZJYL
Jun 30, 2026, 4:30 PM EDT
Filing Type: 6-K/A
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $1.94 info
Change: +$0.120 (+7%) info
Market Cap: $15.029M info
ZJYL
Jun 29, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
10
Price at Filing: $2.23
Real-time Price: $1.94 info
Change: -$0.290 (-13%) info
Market Cap: $15.029M info
ZJYL
Jun 04, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.90
Real-time Price: $1.94 info
Change: -$0.960 (-33%) info
Market Cap: $15.029M info
ZJYL
Apr 07, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.01
Real-time Price: $1.94 info
Change: -$0.070 (-3%) info
Market Cap: $15.029M info
ZJYL
Mar 17, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.35
Real-time Price: $1.94 info
Change: -$0.410 (-17%) info
Market Cap: $15.029M info
ZJYL
Feb 09, 2026, 8:55 PM EST
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.1403
Real-time Price: $1.94 info
Change: Reverse Stock Split info
Market Cap: $15.029M info
ZJYL
Feb 09, 2026, 4:40 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.1403
Real-time Price: $1.94 info
Change: Reverse Stock Split info
Market Cap: $15.029M info
ZJYL
Feb 04, 2026, 8:30 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.1399
Real-time Price: $1.94 info
Change: Reverse Stock Split info
Market Cap: $15.029M info
ZJYL
Jan 22, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.1312
Real-time Price: $1.94 info
Change: Reverse Stock Split info
Market Cap: $15.029M info
ZJYL
Jan 08, 2026, 5:00 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.2695
Real-time Price: $1.94 info
Change: Reverse Stock Split info
Market Cap: $15.029M info